ELEVATION ONCOLOGY INC (ELEV)
Institutional ownership reported to the SEC as of Q3 2025, across 18 quarters.
1
Reporting holders
$720
Reported value
0.0%
Held as options
-58
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| OSAIC HOLDINGS, INC. | $720 | 2,000 | 0.00% | 9q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 1 | $720 | 2,000 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 59 | $10.6M | 28,819,591 | 20 | 10 | 22 | 0.2% |
| Q1 2025 | 66 | $8.7M | 33,589,980 | 14 | 15 | 21 | 0.2% |
| Q4 2024 | 66 | $22.3M | 39,662,665 | 10 | 24 | 9 | 0.0% |
| Q3 2024 | 63 | $26.9M | 44,827,505 | 12 | 20 | 17 | 0.1% |
| Q2 2024 | 77 | $150.8M | 55,965,924 | 25 | 24 | 21 | 0.0% |
| Q1 2024 | 59 | $225.8M | 44,027,794 | 34 | 13 | 9 | 0.0% |
| Q4 2023 | 29 | $13.6M | 25,361,041 | 0 | 6 | 8 | 0.0% |
| Q3 2023 | 38 | $18.3M | 27,544,062 | 7 | 12 | 4 | 0.0% |
| Q2 2023 | 36 | $45.6M | 29,970,225 | 17 | 8 | 4 | 0.0% |
| Q1 2023 | 23 | $26.9M | 14,160,543 | 5 | 8 | 3 | 0.0% |
| Q4 2022 | 21 | $11.5M | 12,126,813 | 6 | 1 | 1 | 0.0% |
| Q3 2022 | 21 | $16.1M | 14,278,557 | 1 | 3 | 4 | 0.0% |
| Q2 2022 | 25 | $21.5M | 15,370,027 | 2 | 5 | 4 | 0.0% |
| Q1 2022 | 28 | $47.2M | 18,712,566 | 4 | 8 | 5 | 0.0% |
| Q4 2021 | 34 | $110.2M | 18,313,786 | 13 | 5 | 5 | 0.0% |
| Q3 2021 | 21 | $123.3M | 15,882,998 | 5 | 3 | 3 | 0.0% |
| Q2 2021 | 36 | $217.2M | 16,192,215 | 36 | 0 | 0 | 0.0% |